Rep. Carter Leads Bills to Lower Drug Costs in E&C FDA Package
May 06, 2022
May 06, 2022
WASHINGTON, May 6 -- Rep. Buddy Carter, R-Georgia, issued the following news release:
The Energy and Commerce Committee unveiled its bipartisan package to reauthorize the Food and Drug Administration (FDA) User Fee Agreements. The package, introduced by Health Subcommittee Republican Leader Brett Guthrie (R-KY) and Health Subcommittee Chairwoman Anna G. Eshoo (D-CA), includes four provisions led by Rep. Earl L. "Buddy" Carter (R-GA) that would lower drug costs, modernize d . . .
The Energy and Commerce Committee unveiled its bipartisan package to reauthorize the Food and Drug Administration (FDA) User Fee Agreements. The package, introduced by Health Subcommittee Republican Leader Brett Guthrie (R-KY) and Health Subcommittee Chairwoman Anna G. Eshoo (D-CA), includes four provisions led by Rep. Earl L. "Buddy" Carter (R-GA) that would lower drug costs, modernize d . . .